You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

maximal safe resection

Showing 1 - 25 of >10,000
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Supramaximal Resection Versus Maximal Resection for High-Grade

Recruiting
  • Glioblastoma
  • +11 more
  • Supramaximal resection
  • Maximal safe resection
  • San Francisco, California
  • +7 more
Nov 1, 2023

Surgically Induced Neurological Deficits in Glioblastomas

Recruiting
  • Glioblastoma
  • Maximal, safe resection of brain tumour
  • Cambridge, United Kingdom
    Stephen Price
Jul 13, 2021

Glioblastoma, Recurrent Glioblastoma, GBM Trial in Santa Monica (Radiation: Intra-operative Radiation Therapy - IORT,

Recruiting
  • Glioblastoma
  • +3 more
  • Radiation: Intra-operative Radiation Therapy - IORT
  • +2 more
  • Santa Monica, California
    Providence Saint John's Health Center
Jul 14, 2022

Glioblastoma, GBM, Recurrent GBM Trial in Chattanooga (Intra-operative Radiation Therapy - IORT)

Recruiting
  • Glioblastoma
  • +2 more
  • Intra-operative Radiation Therapy - IORT
  • Chattanooga, Tennessee
    Southeastern Spine Neurosurgery
Mar 5, 2021

Glioma Trial in Melbourne (Biopsy, Part A: AB-218, Surgery (maximal resection))

Recruiting
  • Glioma
  • Biopsy
  • +3 more
  • Melbourne, Victoria, Australia
    Royal Melbourne Hospital
Oct 11, 2022

CPET to Predict Mortality and Complications of Lung Resection

Recruiting
  • Exercise Test
  • Thoracic Cancer
    • Brussels, Belgium
      Erasme Hospital
    Aug 12, 2022

    Muscle-Invasive Bladder Carcinoma Trial in Roma (Nivolumab, Nab paclitaxel, Cisplatin)

    Not yet recruiting
    • Muscle-Invasive Bladder Carcinoma
    • Roma, Italy
      Roberto iacovelli
    Jan 10, 2022

    Pleural Effusion Recurrence, Pulmonary Resection, Chest Tube Management Trial in Bern (Traditional, Test)

    Completed
    • Pleural Effusion Recurrence
    • +2 more
    • Traditional
    • Test
    • Bern, Switzerland
      Bern University Hospital
    Dec 19, 2022

    The PALSUR-study: Palliative Care Versus Surgery in High-grade

    Recruiting
    • Glioblastoma
    • +3 more
    • Palliative Care
    • +2 more
    • San Francisco, California
    • +7 more
    Nov 18, 2023

    The RESBIOP-study: Resection Versus Biopsy in High-grade Glioma

    Recruiting
    • Glioblastoma
    • +4 more
    • Tumor resection
    • Tumor biopsy
    • San Francisco, California
    • +7 more
    Nov 18, 2023

    Recurrent Glioblastoma Trial in Brussels (Neo-adjuvant nivolumab and ipililumab IV + adjuvant nivolumab and ipililumab IV,

    Not yet recruiting
    • Recurrent Glioblastoma
    • Neo-adjuvant nivolumab and ipililumab IV + adjuvant nivolumab and ipililumab IV
    • +2 more
    • Brussels, Belgium
      UZ Brussel
    Oct 23, 2023

    Intraoperative Ultrasound in Gross Total Resection of Gliomas

    Not yet recruiting
    • Glioma
    • intraoperative ultrasound
    • (no location specified)
    Feb 3, 2023

    Glioblastoma Trial in Toronto (Focused Ultrasound (FUS) BBB Disruption)

    Active, not recruiting
    • Glioblastoma
    • Focused Ultrasound (FUS) BBB Disruption
    • Toronto, Ontario, Canada
      Sunnybrook Health Sciences Centre
    Mar 28, 2022

    Glioblastoma Trial in Worldwide (Surgery followed by adjuvant second-line therapy, Second-line therapy alone)

    Recruiting
    • Glioblastoma
    • Surgery followed by adjuvant second-line therapy
    • Second-line therapy alone
    • Innsbruck, Austria
    • +21 more
    May 10, 2022

    Glioblastoma Multiforme Trial in Los Angeles (drug, radiation, procedure)

    Recruiting
    • Glioblastoma Multiforme
    • Los Angeles, California
      Cedars-Sinai Medical Center
    Feb 24, 2022

    Tumor, Brain, Arteriovenous Malformations, Cavernoma Trial (Functional navigation)

    Not yet recruiting
    • Tumor, Brain
    • +2 more
    • Functional navigation
    • (no location specified)
    Jul 29, 2022

    Glioblastoma, IDH-wildtype Trial in Beijing (Elemene, Placebo)

    Not yet recruiting
    • Glioblastoma, IDH-wildtype
    • Beijing, China
      Peking Union Medical College Hospital
    Apr 22, 2023

    Glioblastoma, Glioblastoma, WHO Grade IV Trial in Gainesville (Temozolomide (TMZ), Optune System, Pembrolizumab)

    Active, not recruiting
    • Glioblastoma
    • Glioblastoma, WHO Grade IV
    • Temozolomide (TMZ)
    • +2 more
    • Gainesville, Florida
      University of Florida Health
    Aug 22, 2022

    Glioblastoma Trial (Surgical tumor resection, GammaTile radiation therapy implantation, Stupp protocol (EBRT and Temozolamide))

    Not yet recruiting
    • Glioblastoma
    • Surgical tumor resection, GammaTile radiation therapy implantation, Stupp protocol (EBRT and Temozolamide)
    • (no location specified)
    Apr 20, 2022

    Primary Glioblastoma Trial in Netherlands (Laser Interstitial Thermal Therapy (LITT), Biopsy)

    Recruiting
    • Primary Glioblastoma
    • Laser Interstitial Thermal Therapy (LITT)
    • Biopsy
    • Amsterdam, Netherlands
    • +6 more
    Nov 1, 2022

    Colon Cancer Trial in Lorenskog, Tonsberg (D3 resection)

    Recruiting
    • Colon Cancer
    • D3 resection
    • Lorenskog, Norway
    • +1 more
    Sep 27, 2020

    Neuroendocrine Tumors Trial in Hyderabad (Endoscopic submucosal dissection, EFTR)

    Recruiting
    • Neuroendocrine Tumors
    • Endoscopic submucosal dissection
    • EFTR
    • Hyderabad, Telangana, India
      Asian institute of Gastroenterology
    Nov 11, 2023

    Recurrent Glioblastoma Trial in Los Angeles (Activated T cells)

    Not yet recruiting
    • Recurrent Glioblastoma
    • Activated T cells
    • Los Angeles, California
      Cedars-Sinai Medical Center
    Apr 21, 2022

    Glioblastoma Multiforme Trial in Montréal (Metformin)

    Active, not recruiting
    • Glioblastoma Multiforme
    • Montréal, Quebec, Canada
      Montreal Neurological Institute - McGill University Health Centr
    Aug 31, 2022

    Glioblastoma Trial in Morgantown (Daratumumab)

    Recruiting
    • Glioblastoma
    • Morgantown, West Virginia
      West Virginia University Cancer Institute Mary Babb Randolph Can
    Dec 5, 2022